Three-dimensional cardiac tissue fabrication based on cell sheet technology

Advanced Drug Delivery Reviews

Volumn 96, Issue , 2016, Pages 103-109

  Masuda, Shinako ^a   Shimizu, Tatsuya ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

Cardiac tubes; Cell sheet engineering; Large scale suspension culture systems; Perfusable 3D cardiac tissues; Pluripotent stem cell derived cardiac cells; Vascularization in 3D cardiac tissues

Indexed keywords

BIOREACTORS; CARDIOLOGY; CELL ENGINEERING; CELLS; CYTOLOGY; DISEASES; HEART; HISTOLOGY; HYDROGELS; SCAFFOLDS (BIOLOGY); STEM CELLS; TISSUE;

BIODEGRADABLE SCAFFOLD; CARDIAC CELL; CARDIAC TISSUE ENGINEERING; CARDIAC TISSUES; CELL SHEET ENGINEERING; CELL SHEET TECHNOLOGIES; SUSPENSION CULTURES; TEMPERATURE-RESPONSIVE;

TISSUE ENGINEERING;

BIOREACTOR; CELL DIFFERENTIATION; CELL SHEET ENGINEERING; COCULTURE; EMBRYONIC STEM CELL; ENDOTHELIUM CELL; EXTRACELLULAR MATRIX; HEART; HEART FAILURE; HEART INFARCTION; HEART MUSCLE CELL; HUMAN; NONHUMAN; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; REVIEW; STEM CELL CULTURE; STEM CELL TRANSPLANTATION; SUSPENSION CELL CULTURE; TISSUE ENGINEERING; TISSUE REGENERATION; VASCULARIZATION; ANIMAL; CARDIAC MUSCLE; CARDIAC MUSCLE CELL; CELL CULTURE TECHNIQUE; CHEMISTRY; CYTOLOGY; PROCEDURES; TISSUE SCAFFOLD;

BIOMATERIAL;

ANIMALS; BIOCOMPATIBLE MATERIALS; CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; HEART FAILURE; HUMANS; MYOCARDIUM; MYOCYTES, CARDIAC; PLURIPOTENT STEM CELLS; TISSUE ENGINEERING; TISSUE SCAFFOLDS;

EID: 84951826305     PISSN: 0169409X     EISSN: 18728294     Source Type: Journal    
DOI: 10.1016/j.addr.2015.05.002     Document Type: Review

References (100)

1. Laflamme M.A., Murry C.E. Regenerating the heart. Nat. Biotechnol. 2005, 23:845-856.
2. Langer R., Vacanti J.P. Tissue engineering. Science 1993, 260:920-926.
3. Eschenhagen T., Fink C., Remmers U., Scholz H., Wattchow J., Weil J., Zimmermann W., Dohmen H.H., Schafer H., Bishopric N., Wakatsuki T., Elson E.L. Three-dimensional reconstitution of embryonic cardiomyocytes in a collagen matrix: a new heart muscle model system. FASEB J. 1997, 11:683-694.
4. Zimmermann W.H., Melnychenko I., Wasmeier G., Didie M., Naito H., Nixdorff U., Hess A., Budinsky L., Brune K., Michaelis B., Dhein S., Schwoerer A., Ehmke H., Eschenhagen T. Engineered heart tissue grafts improve systolic and diastolic function in infarcted rat hearts. Nat. Med. 2006, 12:452-458.
5. Zimmermann W.H., Schneiderbanger K., Schubert P., Didie M., Munzel F., Heubach J.F., Kostin S., Neuhuber W.L., Eschenhagen T. Tissue engineering of a differentiated cardiac muscle construct. Circ. Res. 2002, 90:223-230.
6. Eschenhagen T., Zimmermann W.H., Kleber A.G. Electrical coupling of cardiac myocyte cell sheets to the heart. Circ. Res. 2006, 98:573-575.
7. Fink C., Ergun S., Kralisch D., Remmers U., Weil J., Eschenhagen T. Chronic stretch of engineered heart tissue induces hypertrophy and functional improvement. FASEB J. 2000, 14:669-679.
8. Zimmermann W.H., Didie M., Wasmeier G.H., Nixdorff U., Hess A., Melnychenko I., Boy O., Neuhuber W.L., Weyand M., Eschenhagen T. Cardiac grafting of engineered heart tissue in syngenic rats. Circulation 2002, 106:I151-I157.
9. Ott H.C., Matthiesen T.S., Goh S.K., Black L.D., Kren S.M., Netoff T.I., Taylor D.A. Perfusion-decellularized matrix: using nature's platform to engineer a bioartificial heart. Nat. Med. 2008, 14:213-221.
10. Song J.J., Ott H.C. Organ engineering based on decellularized matrix scaffolds. Trends Mol. Med. 2011, 17:424-432.
11. Moroni F., Mirabella T. Decellularized matrices for cardiovascular tissue engineering. Am. J. Stem Cells 2014, 3:1-20.
12. Lu T.Y., Lin B., Kim J., Sullivan M., Tobita K., Salama G., Yang L. Repopulation of decellularized mouse heart with human induced pluripotent stem cell-derived cardiovascular progenitor cells. Nat. Commun. 2013, 4:2307.
13. Carrier R.L., Papadaki M., Rupnick M., Schoen F.J., Bursac N., Langer R., Freed L.E., Vunjak-Novakovic G. Cardiac tissue engineering: cell seeding, cultivation parameters, and tissue construct characterization. Biotechnol. Bioeng. 1999, 64:580-589.
14. Bursac N., Papadaki M., Cohen R.J., Schoen F.J., Eisenberg S.R., Carrier R., Vunjak-Novakovic G., Freed L.E. Cardiac muscle tissue engineering: toward an in vitro model for electrophysiological studies. Am. J. Physiol. 1999, 277:H433-H444.
15. Li R.K., Jia Z.Q., Weisel R.D., Mickle D.A., Choi A., Yau T.M. Survival and function of bioengineered cardiac grafts. Circulation 1999, 100:II63-II69.
16. Leor J., Aboulafia-Etzion S., Dar A., Shapiro L., Barbash I.M., Battler A., Granot Y., Cohen S. Bioengineered cardiac grafts: a new approach to repair the infarcted myocardium?. Circulation 2000, 102:III56-III61.
17. Radisic M., Park H., Shing H., Consi T., Schoen F.J., Langer R., Freed L.E., Vunjak-Novakovic G. Functional assembly of engineered myocardium by electrical stimulation of cardiac myocytes cultured on scaffolds. Proc. Natl. Acad. Sci. U. S. A. 2004, 101:18129-18134.
18. Hansen A., Eder A., Bonstrup M., Flato M., Mewe M., Schaaf S., Aksehirlioglu B., Schwoerer A.P., Uebeler J., Eschenhagen T. Development of a drug screening platform based on engineered heart tissue. Circ. Res. 2010, 107:35-44.
19. Okano T., Yamada N., Sakai H., Sakurai Y. A novel recovery system for cultured cells using plasma-treated polystyrene dishes grafted with poly(N-isopropylacrylamide). J. Biomed. Mater. Res. 1993, 27:1243-1251.
20. Kushida A., Yamato M., Konno C., Kikuchi A., Sakurai Y., Okano T. Decrease in culture temperature releases monolayer endothelial cell sheets together with deposited fibronectin matrix from temperature-responsive culture surfaces. J. Biomed. Mater. Res. 1999, 45:355-362.
21. Shimizu T., Yamato M., Isoi Y., Akutsu T., Setomaru T., Abe K., Kikuchi A., Umezu M., Okano T. Fabrication of pulsatile cardiac tissue grafts using a novel 3-dimensional cell sheet manipulation technique and temperature-responsive cell culture surfaces. Circ. Res. 2002, 90:e40.
22. Shimizu T., Yamato M., Akutsu T., Shibata T., Isoi Y., Kikuchi A., Umezu M., Okano T. Electrically communicating three-dimensional cardiac tissue mimic fabricated by layered cultured cardiomyocyte sheets. J. Biomed. Mater. Res. 2002, 60:110-117.
23. Haraguchi Y., Shimizu T., Yamato M., Kikuchi A., Okano T. Electrical coupling of cardiomyocyte sheets occurs rapidly via functional gap junction formation. Biomaterials 2006, 27:4765-4774.
24. Shimizu T., Sekine H., Isoi Y., Yamato M., Kikuchi A., Okano T. Long-term survival and growth of pulsatile myocardial tissue grafts engineered by the layering of cardiomyocyte sheets. Tissue Eng. 2006, 12:499-507.
25. Colton C.K. Implantable biohybrid artificial organs. Cell Transplant. 1995, 4:415-436.
26. Carrier R.L., Rupnick M., Langer R., Schoen F.J., Freed L.E., Vunjak-Novakovic G. Perfusion improves tissue architecture of engineered cardiac muscle. Tissue Eng. 2002, 8:175-188.
27. Dvir T., Benishti N., Shachar M., Cohen S. A novel perfusion bioreactor providing a homogenous milieu for tissue regeneration. Tissue Eng. 2006, 12:2843-2852.
28. Radisic M., Deen W., Langer R., Vunjak-Novakovic G. Mathematical model of oxygen distribution in engineered cardiac tissue with parallel channel array perfused with culture medium containing oxygen carriers. Am. J. Physiol. Heart Circ. Physiol. 2005, 288:H1278-H1289.
29. Radisic M., Marsano A., Maidhof R., Wang Y., Vunjak-Novakovic G. Cardiac tissue engineering using perfusion bioreactor systems. Nat. Protoc. 2008, 3:719-738.
30. Radisic M., Park H., Chen F., Salazar-Lazzaro J.E., Wang Y., Dennis R., Langer R., Freed L.E., Vunjak-Novakovic G. Biomimetic approach to cardiac tissue engineering: oxygen carriers and channeled scaffolds. Tissue Eng. 2006, 12:2077-2091.
31. Radisic M., Yang L., Boublik J., Cohen R.J., Langer R., Freed L.E., Vunjak-Novakovic G. Medium perfusion enables engineering of compact and contractile cardiac tissue. Am. J. Physiol. Heart Circ. Physiol. 2004, 286:H507-H516.
32. Hossler F.E., Douglas J.E. Vascular corrosion casting: review of advantages and limitations in the application of some simple quantitative methods. Microsc. Microanal. 2001, 7:253-264.
33. Rakusan K., Flanagan M.F., Geva T., Southern J., Van Praagh R. Morphometry of human coronary capillaries during normal growth and the effect of age in left ventricular pressure-overload hypertrophy. Circulation 1992, 86:38-46.
34. Shimizu T., Sekine H., Yang J., Isoi Y., Yamato M., Kikuchi A., Kobayashi E., Okano T. Polysurgery of cell sheet grafts overcomes diffusion limits to produce thick, vascularized myocardial tissues. FASEB J. 2006, 20:708-710.
35. Kirkpatrick C.J., Fuchs S., Unger R.E. Co-culture systems for vascularization-learning from nature. Adv. Drug Deliv. Rev. 2011, 63:291-299.
36. Sekiya S., Shimizu T., Yamato M., Kikuchi A., Okano T. Bioengineered cardiac cell sheet grafts have intrinsic angiogenic potential. Biochem. Biophys. Res. Commun. 2006, 341:573-582.
37. Sasagawa T., Shimizu T., Sekiya S., Haraguchi Y., Yamato M., Sawa Y., Okano T. Design of prevascularized three-dimensional cell-dense tissues using a cell sheet stacking manipulation technology. Biomaterials 2010, 31:1646-1654.
38. Asakawa N., Shimizu T., Tsuda Y., Sekiya S., Sasagawa T., Yamato M., Fukai F., Okano T. Pre-vascularization of in vitro three-dimensional tissues created by cell sheet engineering. Biomaterials 2010, 31:3903-3909.
39. Sekine H., Shimizu T., Hobo K., Sekiya S., Yang J., Yamato M., Kurosawa H., Kobayashi E., Okano T. Endothelial cell coculture within tissue-engineered cardiomyocyte sheets enhances neovascularization and improves cardiac function of ischemic hearts. Circulation 2008, 118:S145-S152.
40. Stevens K.R., Kreutziger K.L., Dupras S.K., Korte F.S., Regnier M., Muskheli V., Nourse M.B., Bendixen K., Reinecke H., Murry C.E. Physiological function and transplantation of scaffold-free and vascularized human cardiac muscle tissue. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:16568-16573.
41. Tulloch N.L., Muskheli V., Razumova M.V., Korte F.S., Regnier M., Hauch K.D., Pabon L., Reinecke H., Murry C.E. Growth of engineered human myocardium with mechanical loading and vascular coculture. Circ. Res. 2011, 109:47-59.
42. Lesman A., Habib M., Caspi O., Gepstein A., Arbel G., Levenberg S., Gepstein L. Transplantation of a tissue-engineered human vascularized cardiac muscle. Tissue Eng. A 2010, 16:115-125.
43. Caspi O., Lesman A., Basevitch Y., Gepstein A., Arbel G., Habib I.H., Gepstein L., Levenberg S. Tissue engineering of vascularized cardiac muscle from human embryonic stem cells. Circ. Res. 2007, 100:263-272.
44. Takeuchi R., Kuruma Y., Sekine H., Dobashi I., Yamato M., Umezu M., Shimizu T., Okano T. In vivo vascularization of cell sheets provided better long-term tissue survival than injection of cell suspension. J. Tissue Eng. Regen. Med. 2015, (in press).
45. Morritt A.N., Bortolotto S.K., Dilley R.J., Han X., Kompa A.R., McCombe D., Wright C.E., Itescu S., Angus J.A., Morrison W.A. Cardiac tissue engineering in an in vivo vascularized chamber. Circulation 2007, 115:353-360.
46. Tee R., Morrison W.A., Dusting G.J., Liu G.S., Choi Y.S., Hsiao S.T., Dilley R.J. Transplantation of engineered cardiac muscle flaps in syngeneic rats. Tissue Eng. A 2012, 18:1992-1999.
47. Sekine H., Shimizu T., Sakaguchi K., Dobashi I., Wada M., Yamato M., Kobayashi E., Umezu M., Okano T. In vitro fabrication of functional three-dimensional tissues with perfusable blood vessels. Nat. Commun. 2013, 4:1399.
48. Sakaguchi K., Shimizu T., Horaguchi S., Sekine H., Yamato M., Umezu M., Okano T. In vitro engineering of vascularized tissue surrogates. Sci. Rep. 2013, 3:1316.
49. Vollert I., Seiffert M., Bachmair J., Sander M., Eder A., Conradi L., Vogelsang A., Schulze T., Uebeler J., Holnthoner W., Redl H., Reichenspurner H., Hansen A., Eschenhagen T. In vitro perfusion of engineered heart tissue through endothelialized channels. Tissue Eng. A 2014, 20:854-863.
50. Yildirim Y., Naito H., Didie M., Karikkineth B.C., Biermann D., Eschenhagen T., Zimmermann W.H. Development of a biological ventricular assist device: preliminary data from a small animal model. Circulation 2007, 116:I16-I23.
51. Kubo H., Shimizu T., Yamato M., Fujimoto T., Okano T. Creation of myocardial tubes using cardiomyocyte sheets and an in vitro cell sheet-wrapping device. Biomaterials 2007, 28:3508-3516.
52. Sekine H., Shimizu T., Yang J., Kobayashi E., Okano T. Pulsatile myocardial tubes fabricated with cell sheet engineering. Circulation 2006, 114:I87-I93.
53. Orlic D., Kajstura J., Chimenti S., Jakoniuk I., Anderson S.M., Li B., Pickel J., McKay R., Nadal-Ginard B., Bodine D.M., Leri A., Anversa P. Bone marrow cells regenerate infarcted myocardium. Nature 2001, 410:701-705.
54. Taylor D.A., Atkins B.Z., Hungspreugs P., Jones T.R., Reedy M.C., Hutcheson K.A., Glower D.D., Kraus W.E. Regenerating functional myocardium: improved performance after skeletal myoblast transplantation. Nat. Med. 1998, 4:929-933.
55. Asahara T., Murohara T., Sullivan A., Silver M., van der Zee R., Li T., Witzenbichler B., Schatteman G., Isner J.M. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997, 275:964-967.
56. Jujo K., Ii M., Losordo D.W. Endothelial progenitor cells in neovascularization of infarcted myocardium. J. Mol. Cell. Cardiol. 2008, 45:530-544.
57. Caplan A.I. Mesenchymal stem cells. J. Orthop. Res. 1991, 9:641-650.
58. Makino S., Fukuda K., Miyoshi S., Konishi F., Kodama H., Pan J., Sano M., Takahashi T., Hori S., Abe H., Hata J., Umezawa A., Ogawa S. Cardiomyocytes can be generated from marrow stromal cells in vitro. J. Clin. Invest. 1999, 103:697-705.
59. Garbern J.C., Lee R.T. Cardiac stem cell therapy and the promise of heart regeneration. Cell Stem Cell 2013, 12:689-698.
60. Kajstura J., Urbanek K., Rota M., Bearzi C., Hosoda T., Bolli R., Anversa P., Leri A. Cardiac stem cells and myocardial disease. J. Mol. Cell. Cardiol. 2008, 45:505-513.
61. Evans M.J., Kaufman M.H. Establishment in culture of pluripotential cells from mouse embryos. Nature 1981, 292:154-156.
62. Thomson J.A., Itskovitz-Eldor J., Shapiro S.S., Waknitz M.A., Swiergiel J.J., Marshall V.S., Jones J.M. Embryonic stem cell lines derived from human blastocysts. Science 1998, 282:1145-1147.
63. Takahashi K., Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006, 126:663-676.
64. Takahashi K., Tanabe K., Ohnuki M., Narita M., Ichisaka T., Tomoda K., Yamanaka S. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007, 131:861-872.
65. He J.Q., Ma Y., Lee Y., Thomson J.A., Kamp T.J. Human embryonic stem cells develop into multiple types of cardiac myocytes: action potential characterization. Circ. Res. 2003, 93:32-39.
66. Zhang J., Wilson G.F., Soerens A.G., Koonce C.H., Yu J., Palecek S.P., Thomson J.A., Kamp T.J. Functional cardiomyocytes derived from human induced pluripotent stem cells. Circ. Res. 2009, 104:e30-e41.
67. Caspi O., Huber I., Kehat I., Habib M., Arbel G., Gepstein A., Yankelson L., Aronson D., Beyar R., Gepstein L. Transplantation of human embryonic stem cell-derived cardiomyocytes improves myocardial performance in infarcted rat hearts. J. Am. Coll. Cardiol. 2007, 50:1884-1893.
68. Laflamme M.A., Chen K.Y., Naumova A.V., Muskheli V., Fugate J.A., Dupras S.K., Reinecke H., Xu C., Hassanipour M., Police S., O'Sullivan C., Collins L., Chen Y., Minami E., Gill E.A., Ueno S., Yuan C., Gold J., Murry C.E. Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts. Nat. Biotechnol. 2007, 25:1015-1024.
69. van Laake L.W., Passier R., Monshouwer-Kloots J., Verkleij A.J., Lips D.J., Freund C., den Ouden K., Ward-van Oostwaard D., Korving J., Tertoolen L.G., van Echteld C.J., Doevendans P.A., Mummery C.L. Human embryonic stem cell-derived cardiomyocytes survive and mature in the mouse heart and transiently improve function after myocardial infarction. Stem Cell Res. 2007, 1:9-24.
70. Miki K., Uenaka H., Saito A., Miyagawa S., Sakaguchi T., Higuchi T., Shimizu T., Okano T., Yamanaka S., Sawa Y. Bioengineered myocardium derived from induced pluripotent stem cells improves cardiac function and attenuates cardiac remodeling following chronic myocardial infarction in rats. Stem Cells Transl. Med. 2012, 1:430-437.
71. Kawamura M., Miyagawa S., Miki K., Saito A., Fukushima S., Higuchi T., Kawamura T., Kuratani T., Daimon T., Shimizu T., Okano T., Sawa Y. Feasibility, safety, and therapeutic efficacy of human induced pluripotent stem cell-derived cardiomyocyte sheets in a porcine ischemic cardiomyopathy model. Circulation 2012, 126:S29-S37.
72. Zhang Y., Wang D., Chen M., Yang B., Zhang F., Cao K. Intramyocardial transplantation of undifferentiated rat induced pluripotent stem cells causes tumorigenesis in the heart. PLoS One 2011, 6:e19012.
73. Gutierrez-Aranda I., Ramos-Mejia V., Bueno C., Munoz-Lopez M., Real P.J., Macia A., Sanchez L., Ligero G., Garcia-Parez J.L., Menendez P. Human induced pluripotent stem cells develop teratoma more efficiently and faster than human embryonic stem cells regardless the site of injection. Stem Cells 2010, 28:1568-1570.
74. Stadtfeld M., Nagaya M., Utikal J., Weir G., Hochedlinger K. Induced pluripotent stem cells generated without viral integration. Science 2008, 322:945-949.
75. Okita K., Nakagawa M., Hyenjong H., Ichisaka T., Yamanaka S. Generation of mouse induced pluripotent stem cells without viral vectors. Science 2008, 322:949-953.
76. Kaji K., Norrby K., Paca A., Mileikovsky M., Mohseni P., Woltjen K. Virus-free induction of pluripotency and subsequent excision of reprogramming factors. Nature 2009, 458:771-775.
77. Woltjen K., Michael I.P., Mohseni P., Desai R., Mileikovsky M., Hamalainen R., Cowling R., Wang W., Liu P., Gertsenstein M., Kaji K., Sung H.K., Nagy A. piggyBac transposition reprograms fibroblasts to induced pluripotent stem cells. Nature 2009, 458:766-770.
78. Yusa K., Rad R., Takeda J., Bradley A. Generation of transgene-free induced pluripotent mouse stem cells by the piggyBac transposon. Nat. Methods 2009, 6:363-369.
79. Fusaki N., Ban H., Nishiyama A., Saeki K., Hasegawa M. Efficient induction of transgene-free human pluripotent stem cells using a vector based on Sendai virus, an RNA virus that does not integrate into the host genome. Proc. Jpn. Acad. Ser. B Phys. Biol. Sci. 2009, 85:348-362.
80. Zhou H., Wu S., Joo J.Y., Zhu S., Han D.W., Lin T., Trauger S., Bien G., Yao S., Zhu Y., Siuzdak G., Scholer H.R., Duan L., Ding S. Generation of induced pluripotent stem cells using recombinant proteins. Cell Stem Cell 2009, 4:381-384.
81. Kim D., Kim C.H., Moon J.I., Chung Y.G., Chang M.Y., Han B.S., Ko S., Yang E., Cha K.Y., Lanza R., Kim K.S. Generation of human induced pluripotent stem cells by direct delivery of reprogramming proteins. Cell Stem Cell 2009, 4:472-476.
82. Warren L., Manos P.D., Ahfeldt T., Loh Y.H., Li H., Lau F., Ebina W., Mandal P.K., Smith Z.D., Meissner A., Daley G.Q., Brack A.S., Collins J.J., Cowan C., Schlaeger T.M., Rossi D.J. Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA. Cell Stem Cell 2010, 7:618-630.
83. Carvajal-Vergara X., Sevilla A., D'Souza S.L., Ang Y.S., Schaniel C., Lee D.F., Yang L., Kaplan A.D., Adler E.D., Rozov R., Ge Y., Cohen N., Edelmann L.J., Chang B., Waghray A., Su J., Pardo S., Lichtenbelt K.D., Tartaglia M., Gelb B.D., Lemischka I.R. Patient-specific induced pluripotent stem-cell-derived models of LEOPARD syndrome. Nature 2010, 465:808-812.
84. Moretti A., Bellin M., Welling A., Jung C.B., Lam J.T., Bott-Flugel L., Dorn T., Goedel A., Hohnke C., Hofmann F., Seyfarth M., Sinnecker D., Schomig A., Laugwitz K.L. Patient-specific induced pluripotent stem-cell models for long-QT syndrome. N. Engl. J. Med. 2010, 363:1397-1409.
85. Itzhaki I., Maizels L., Huber I., Zwi-Dantsis L., Caspi O., Winterstern A., Feldman O., Gepstein A., Arbel G., Hammerman H., Boulos M., Gepstein L. Modelling the long QT syndrome with induced pluripotent stem cells. Nature 2011, 471:225-229.
86. Sun N., Yazawa M., Liu J., Han L., Sanchez-Freire V., Abilez O.J., Navarrete E.G., Hu S., Wang L., Lee A., Pavlovic A., Lin S., Chen R., Hajjar R.J., Snyder M.P., Dolmetsch R.E., Butte M.J., Ashley E.A., Longaker M.T., Robbins R.C., Wu J.C. Patient-specific induced pluripotent stem cells as a model for familial dilated cardiomyopathy. Sci. Transl. Med. 2012, 4. (130ra147).
87. Kim C., Wong J., Wen J., Wang S., Wang C., Spiering S., Kan N.G., Forcales S., Puri P.L., Leone T.C., Marine J.E., Calkins H., Kelly D.P., Judge D.P., Chen H.S. Studying arrhythmogenic right ventricular dysplasia with patient-specific iPSCs. Nature 2013, 494:105-110.
88. Matsuura K., Masuda S., Haraguchi Y., Yasuda N., Shimizu T., Hagiwara N., Zandstra P.W., Okano T. Creation of mouse embryonic stem cell-derived cardiac cell sheets. Biomaterials 2011, 32:7355-7362.
89. Matsuura K., Wada M., Konishi K., Sato M., Iwamoto U., Sato Y., Tachibana A., Kikuchi T., Iwamiya T., Shimizu T., Yamashita J.K., Yamato M., Hagiwara N., Okano T. Fabrication of mouse embryonic stem cell-derived layered cardiac cell sheets using a bioreactor culture system. PLoS One 2012, 7:e52176.
90. Matsuura K., Wada M., Shimizu T., Haraguchi Y., Sato F., Sugiyama K., Konishi K., Shiba Y., Ichikawa H., Tachibana A., Ikeda U., Yamato M., Hagiwara N., Okano T. Creation of human cardiac cell sheets using pluripotent stem cells. Biochem. Biophys. Res. Commun. 2012, 425:321-327.
91. Uosaki H., Fukushima H., Takeuchi A., Matsuoka S., Nakatsuji N., Yamanaka S., Yamashita J.K. Efficient and scalable purification of cardiomyocytes from human embryonic and induced pluripotent stem cells by VCAM1 surface expression. PLoS One 2011, 6:e23657.
92. Dubois N.C., Craft A.M., Sharma P., Elliott D.A., Stanley E.G., Elefanty A.G., Gramolini A., Keller G. SIRPA is a specific cell-surface marker for isolating cardiomyocytes derived from human pluripotent stem cells. Nat. Biotechnol. 2011, 29:1011-1018.
93. Rust W., Balakrishnan T., Zweigerdt R. Cardiomyocyte enrichment from human embryonic stem cell cultures by selection of ALCAM surface expression. Regen. Med. 2009, 4:225-237.
94. Hattori F., Chen H., Yamashita H., Tohyama S., Satoh Y.S., Yuasa S., Li W., Yamakawa H., Tanaka T., Onitsuka T., Shimoji K., Ohno Y., Egashira T., Kaneda R., Murata M., Hidaka K., Morisaki T., Sasaki E., Suzuki T., Sano M., Makino S., Oikawa S., Fukuda K. Nongenetic method for purifying stem cell-derived cardiomyocytes. Nat. Methods 2010, 7:61-66.
95. Ban K., Wile B., Kim S., Park H.J., Byun J., Cho K.W., Saafir T., Song M.K., Yu S.P., Wagner M., Bao G., Yoon Y.S. Purification of cardiomyocytes from differentiating pluripotent stem cells using molecular beacons that target cardiomyocyte-specific mRNA. Circulation 2013, 128:1897-1909.
96. Klug M.G., Soonpaa M.H., Koh G.Y., Field L.J. Genetically selected cardiomyocytes from differentiating embryonic stem cells form stable intracardiac grafts. J. Clin. Invest. 1996, 98:216-224.
97. Xu X.Q., Zweigerdt R., Soo S.Y., Ngoh Z.X., Tham S.C., Wang S.T., Graichen R., Davidson B., Colman A., Sun W. Highly enriched cardiomyocytes from human embryonic stem cells. Cytotherapy 2008, 10:376-389.
98. Matsuura K., Kodama F., Sugiyama K., Shimizu T., Hagiwara N., Okano T. Elimination of remaining undifferentiated induced pluripotent stem cells in the process of human cardiac cell sheet fabrication using a methionine-free culture condition. Tissue Eng. Part C Methods 2015, 21:330-338.
99. Masumoto H., Ikuno T., Takeda M., Fukushima H., Marui A., Katayama S., Shimizu T., Ikeda T., Okano T., Sakata R., Yamashita J.K. Human iPS cell-engineered cardiac tissue sheets with cardiomyocytes and vascular cells for cardiac regeneration. Sci. Rep. 2014, 4:6716.
100. Masumoto H., Matsuo T., Yamamizu K., Uosaki H., Narazaki G., Katayama S., Marui A., Shimizu T., Ikeda T., Okano T., Sakata R., Yamashita J.K. Pluripotent stem cell-engineered cell sheets reassembled with defined cardiovascular populations ameliorate reduction in infarct heart function through cardiomyocyte-mediated neovascularization. Stem Cells 2012, 30:1196-1205.